Expanded U.S. footprint YMC America recently expanded its U.S. manufacturing and operations in Devens, MA, signaling capacity growth and readiness to support increased demand for GMP-compliant chromatography systems and DAC columns for peptide, oligonucleotide, and small molecule APIs.

Integrated chromatography solutions The company combines downstream design, automation, and manufacturing with in-line processes (BID, caustic dilution, blending) and SMB licensing through ChromaCon, presenting a single-source offer for continuous and batch chromatography needs across pharma and biotech pipelines.

Regulatory and quality alignment With experience meeting BPE, cGMP, GAMP, and 21 CFR standards under ISO 9001:2015 QMS, YMC can target customers requiring compliant, scalable, and auditable chromatography and resin/silica packing chemistries.

Passion for continuous Strategic acquisitions of LEWA Bioprocess Group and ChromaCon enhance capabilities in continuous chromatography and advanced multi-column systems, enabling sales opportunities in high-efficiency, scalable processing lines for biopharma and chemical manufacturing.

Industry engagement Active participation in industry events such as ASMS and Pittcon, along with a history of launching advanced products like YMC-Triart Bio C18 and N-Rich techniques, creates touchpoints for lead generation and demonstrates ongoing innovation and market relevance.